STANDARD OPERATING PROCEDURE
|
|
- Moris Evans
- 5 years ago
- Views:
Transcription
1 STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Melanie Boulter, QA Auditor Teresa O Leary, Head of Regulatory Compliance Authorisation (Original signatures are retained by Research & Innovation) Dr Stephen Ryder Director of Research & Innovation Dr Stephen Fowlie Medical Director 01 st Aug nd Sep 2016 USERS OF THIS STANDARD OPERATING PROCEDURE MUST REFER TO TO ENSURE THE MOST CURRENT VERSION IS BEING USED
2 Page 2 of 8 1. Document History Version Number Issue Date Reason for Change 1 30 th May 2014 Original SOP th Sep 2016 Biennial Review and updated based on Audit
3 Page 3 of 8 2. Introduction Sponsors must ensure that there are systems in place to address quality and/or compliance deficiencies or any other issues ( deficiencies ) identified on studies that cannot be resolved by the study team or sponsor within an appropriate timeframe. Deficiencies that require formal monitoring by the sponsor will be added to a corrective and preventative action (CAPA) form. The CAPA form will include details of the deficiency and staff responsible for implementing appropriate corrective and preventative action together with a timeframe and allows the escalation of deficiencies to senior management when necessary. 3. Purpose and Scope This standard operating procedure (SOP) describes the process for the initiation, tracking and recording of CAPAs to resolve deficiencies identified from various sources including, but not limited to, audits conducted by- or on behalf of- Nottingham University Hospitals NHS Trust (NUH). This SOP will apply for studies sponsored by NUH. For studies not sponsored by NUH any deficiencies must be reported to the individual study sponsor in the first instance. Individual sponsors may contact NUH for support on addressing any deficiencies pertaining to their research study being conducted at NUH. 4. Responsibilities All Research Staff Any staff member undertaking research activities for an NUH sponsored study is responsible for the identification and reporting of deficiencies to the sponsor. Research staff will participate in investigations as applicable, and may act as CAPA owner. CAPA Owner Ensure completion of assigned CAPA. Sponsor (fulfilled by the Research and Innovation (R&) department on behalf of NUH as sponsor) The R&I Head of Regulatory Compliance (HRC) will co-ordinate completion of assigned CAPA, and ensure it is appropriately documented and tracked to completion. The HRC or QAA will escalate any critical deficiencies to the Director and/or Deputy Director of R&I. The Director and/or Deputy Director of R&I will support resolution of critical deficiencies, and may escalate these to the Clinical Director and/or Medical Director.
4 Page 4 of 8 5. Definitions CAPA CMD CTIMP Deficiency GCP HRC ICH NUH QA QAA R&I Serious Breach SOP TMF 6. Procedure Corrective and Preventative Action Clinical Investigation of a Medical Device Clinical Trial of an Investigational Medicinal Product Event or circumstance which affects, or has the potential to affect, the overall quality and compliance of the research study or risk to NUH Good Clinical Practice Head of Regulatory Compliance International Conference on Harmonisation Nottingham University Hospitals NHS Trust Quality Assurance Quality Assurance Auditor Research and Innovation A breach of the conditions and principles of GCP in connection with a study, or of the protocol relating to a study, which is likely to effect to a significant degree (a) the safety or physical or mental integrity of the participants; or (b) the scientific value of the study. This also includes serious and/or repeated non-compliance with applicable regulations and/or the protocol Standard Operating Procedures Trial Master File 6.1 Identification of a Quality or Compliance Deficiency Deficiencies may be identified by research teams, study managers, third party providers, monitors, auditors or regulatory inspectors. For a significant deficiency that may potentially be a serious breach, this must be done within 24 hours of becoming aware it. Any staff member may also report deficiencies to R&I by (ResearchSponsor@nuh.nhs.uk), by telephone ( ) or in person by visiting the Nottingham Health Science Partners, C-Floor, South Block, QMC. R&I should also be contacted for queries about research quality or compliance. R&I accepts deficiencies identified from (but not limited to): i. Staff Observations; ii. Audits; iii. Deviations;
5 Page 5 of 8 iv. Regulatory Inspections; v. Urgent Safety Measures; vi. Suspected Fraud or Misconduct; vii. Potential Serious Breaches. 6.2 Implementing Corrective and Preventative Action On receipt of the deficiency notification R&I will determine the classification of the deficiency (see Appendix 2) and assess any CAPA that may have already been implemented and by whom as provided in the initial notification Minor Deficiencies Minor deficiencies do not require CAPA reporting but this may be initiated if further action to resolve the minor deficiency is required. If it is felt a CAPA is required this will be communicated back to the relevant staff/department. All CAPA must be documented (CAPA Form (TAFQ00801)), this form contains guidance on how to complete which can be deleted once a CAPA is drafted. Several recurring minor deficiencies should be re-classed as major and handled as described in section Major or Critical Deficiencies After receiving notification of a major deficiency the HRC, or delegate, must initiate a Corrective and Preventative action plan. The HRC will raise a CAPA Form (TAFQ00801) and record the CAPA by entering all relevant details onto the CAPA log (TAFQ00802) taking the next sequential reference number. The CAPA numbering scheme is: CAYY-XX. A suitable CAPA owner will be identified through discussion and agreement with the responsible individual/department, and the form sent to them to complete. The CAPA owner will complete the CAPA form as far as proposing (as appropriate): i. Corrective actions in order to address the actual deficiency; and ii. Preventive actions in order to address any systematic failures that may allow recurrence of deficiency.
6 Page 6 of 8 When considering preventive actions the CAPA owner should explore and, where reasonable, investigate the root causes of the reasons for the deficiency. The CAPA should: i. Specify exactly what must be accomplished; ii. Give a measure that can be determined to show that the action has been achieved; iii. Only set actions that may reasonably be completed; iv. The action must not lose sight of the original deficiency; v. Define the deadline for completion. The CAPA owner must assess if a route cause analysis is required and provide details of the root cause. The CAPA owner returns the CAPA form to the HRC or delegate. The HRC or delegate then reviews the CAPA form to assess whether the proposed actions adequately address the deficiency and its root cause. If acceptable the HRC or delegate, will approve the CAPA, retain a copy for R&I records and return the original to the CAPA owner to complete the task as stated. After completion of all actions the CAPA owner will update the CAPA form and send the form back to the HRC or delegate. The HRC or delegate will assess whether the CAPA reported is complete and effective in addressing the original deficiency. The HRC or delegate will update the CAPA form to close the actions and file in R&I files and the TMF, if study-related. CAPA owners must notify the HRC, or delegate, of any delays with the completion of assigned actions. The HRC, or delegate, will escalate all critical deficiencies related to CTIMPs & CMDs to the Director and/or Deputy Director of R&I. Dependent on the deficiency the Director and/or Deputy Director of R&I may deem it appropriate to escalate further to the Clinical Director and/or Medical Director (i.e. in cases of fraud and misconduct). R&I may decide to withdraw or suspend sponsorship for the study in some cases of major or critical deficiencies. This will be communicated to the Chief Investigator and the appropriate processes followed (SOP-RES-001 Sponsorship and SOP-RES-025 End of Study Notification and Premature Discontinuation of a Study). 6.3 Corrective and Preventative Action Review Periodically (usually monthly) the HRC or delegate, will review the status of outstanding CAPAs and escalate any significant delays to CTIMP & CMD related CAPAs the Director and/or Deputy Director of R&I.
7 Page 7 of 8 The HRC or delegate will chase the CAPA owner of any actions that are not closed within the agreed timelines. Failure to implement the CAPA within an appropriate timeline may affect the continuation of NUH sponsorship for a study. The HRC or delegate will communicate CAPA progress as part of quarterly QA metrics to senior management and R&I team. 7. References and Associated Documents International Conference on Harmonisation Guidelines on Good Clinical Practice E6 (R1) TAFQ00801 TAFQ00802 TAFR01701 SOP-RES-001 SOP-RES-025 CAPA Form CAPA Log Deviation Report Sponsorship End of Study Notification and Premature Discontinuation of a Study
8 Page 8 of 8 8. Appendices Appendix 1. Classification of Deficiencies Classification Definition A single event whereby compliance with procedures, instructions, regulations or sponsor requirements has lapsed. Immediate corrective action may be implemented so there is no overall impact on participant safety or the outcome of the study. The Minor* isolated event does not suggest failure of the quality management system. N.B. Several isolated events of a similar nature may be reclassified as Major. A single event or several isolated events, whereby procedures, instructions, regulations or sponsor requirements have not been followed. Corrective action may be implemented but the event(s) Major* has the potential to impact participant safety or the overall outcome of the study. The event(s) indicate a flaw or gap in the quality management system which may be rectified following implementation of appropriate preventive action. A single event, or series of events, whereby procedures, instructions, regulations or sponsor requirements have not been followed. Corrective action may be implemented, or may not be possible. The event(s) are deemed to be a high risk to Critical* participant safety or to the outcome and/or the integrity of the study. The event(s) indicate the total breakdown or inadequacy of the quality management system. Preventive action and quality improvements must be implemented with immediate effect. *Quality issues may be re-classified following an investigation.
STANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number End of Study Report SOP-RES-027 Version Number 2 Issue Date 15 Apr 2016 Effective Date 26 May 2016 Review Date 26 May 2018 Author(s) Reviewer(s) Natalie
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Urgent Safety Measures SOP-RES-022 Version Number 1 Issue Date 30 th April 2014 Effective Date 28 th May 2014 Review Date 28 th May 2016 Author(s) Reviewer(s)
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Risk Assessment SOP-RES-002 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s)
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title SOP Index Number SOP 21 Version 4.0 Approval Date Effective Date Non-Compliance: Deviations and Serious Breaches of GCP and/or
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Adverse Event Reporting in Clinical Medical Device Trials SOP-RES-033 Version Number 1 Issue Date 08 th Dec 2015 Effective Date 22 nd January 2016 Review
More information1. INTRODUCTION 2. SCOPE 3. PROCESS
1. INTRODUCTION This document describes the procedure for establishing and maintaining records for staff training and complies with the principles of good clinical practice (GCP) for clinical trials of
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Adverse Event Identification, Recording and Reporting in Clinical Trials of Investigational Medicinal SOP-RES-019 Version Number 2 Issue Date 08 th Dec
More informationMANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS
MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS DOCUMENT NO.: CR010 v4.0 AUTHOR: Heather Charles ISSUE DATE: 01 September 2016 EFFECTIVE DATE: 15 September 2016 1 INTRODUCTION 1.1 The Academic
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationStandard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research
Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/002 Version V2.0 07 Apr 2016 Document Author(s) Document Reviewer(s)
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM-005 SOP category: Trial Management Version number: 04 Version date: 10 July
More informationStandard Operating Procedure (SOP)
Standard Operating Procedure MANAGEMENT OF BREACHES IN RESEARCH SETTING AUDIENCE ISSUE Trustwide for research sponsored by UHBristol All research staff involved in UH Bristol sponsored research This SOP
More informationMarie-Claire Rickard, Governance and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of or the Trial Protocol SOP Number: 037 Version Number: 5.0 Effective Date: 17/6/16 Review Date: 17/6/18 Author: Reviewer: Reviewer
More informationSOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager QA Approval: Richard Cowie, QA Manager Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Site Selection and Initiation SOP number: TM 005 SOP category: Trial Management Version number: 03 Version date: 19 December
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Recording and Reporting Deviations, Violations, Potential Serious Breaches, Serious Breaches and Urgent Safety Measures
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationACTIONS/PSOP/001 Version 1.0 Page 2 of 6
1. The purpose of the Pharmacy Site File To enable the designated trust pharmacy to fulfil its role and exercise appropriate control over all aspects of study medication handling, an accurately maintained
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationSTANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office
STANDARD OPERATING PROCEDURE SOP 220 Investigation of allegations of Research Fraud and Misconduct Version 1.4 Version date 27.02.2018 Effective date 2.03.2018 Number of pages 8 Review date February 2020
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationQuality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D
Quality Assurance in Clinical Research at RM/ICR GCP Compliance Team, Clinical R&D Slide 1 of 13 What is Quality Assurance? The maintenance of a desired level of quality in a service or product, especially
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationSOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection
SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection Authorship Team: Jemma Hughes, Tina Morgan, for Joint SOP Group on Trial Processes (viz Leanne Quinn, Ian Russell, Anne
More informationResearch Staff Training
REFERENCE: VERSION NUMBER: 3.0 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Research Infrastructure Manager REVIEWED BY: Research & Innovation Group APPROVED BY: Deputy Director of Research CONTROLLER:
More informationThis Agreement dated DD/MM/YYYY (the Effective Date ) is between
Clinical Trial Delegation of Sponsorship Responsibilities to Chief This Agreement dated DD/MM/YYYY (the Effective Date ) is between Nottingham University Hospitals NHS Trust, Derby Road, Nottingham, NG7
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationSafety Reporting in Clinical Research Policy Final Version 4.0
Safety Reporting in Clinical Research Policy Final Version 4.0 Category: Summary: Equality Assessment undertaken: Impact Policy The Medicines for Human Use (Clinical Trials) Regulations 2004 and subsequent
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Risk Assessment of NCTU Studies SOP number: TM-020 SOP category: Trial Management Version number: 02 Version date: 16
More informationGuideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
1 2 31 January 2017 EMA/430909/2016 3 4 5 Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or Draft Adopted by GCP Inspectors Working Group (GCP IWG) 30 January 2017 Adopted
More informationSTANDARD OPERATING PROCEDURE SOP 325
STANDARD OPERATING PROCEDURE SOP 325 STUDY START UP ACTIVITIES FOR CLINICAL RESEARCH TRIALS Version 1.4 Version date 28.03.2017 Effective date 28.03.2017 Number of pages 7 Review date April 2019 Author
More informationStandard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol
Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH SETTING FOR STAFF ISSUE Trustwide Chief and Principal Investigators of research sponsored and/or hosted by UHBristol Oversight of research
More informationResearch Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review
Effective: 12/04/2013 Reviewed: 12/04/2015 Name of Associated Policy: Palmetto Health Administrative Research Review Definitions Responsible Positions Equipment Needed Procedure Steps, Guidelines, Rules,
More informationOnce the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;
1. INTRODUCTION 2. SCOPE Feasibility assessments will ascertain any operational concerns about a research study which may delay NHS Permission or cause issues with study delivery. By conducting an assessment
More informationDocument Title: Informed Consent for Research Studies
Document Title: Informed Consent for Research Studies Document Number: SOP003 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D
More informationStorage and Archiving of Research Documents SOP 6
Storage and Archiving of Research Documents SOP 6 SOP Title Storage and Archiving or Research Documents (Formerly Storage and Archiving Requirements ) SOP No. SOP 6 Author Consulted Departments Lead Manager
More informationDocument Title: File Notes. Document Number: 024
Document Title: File Notes Document Number: 024 Version: 1.2 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel
More informationMarie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager
Standard Operating Procedures (SOP) for: Pharmacovigilance processing for the JRMO SOP Number: 26c Version Number: V1 Effective Date: 5/8/16 Review Date: 5/8/17 Author: Reviewer: Reviewer: Authorisation:
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationDocument Title: Version Control of Study Documents. Document Number: 023
Document Title: Version Control of Study Documents Document Number: 023 Version: 1.1 Ratified by: Committee Date ratified: 03 OCT 2017 Name of originator/author: Directorate: Department: Name of responsible
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1 Ratified by: Committee Date ratified: 30 September 2014 Name of originator/author: Directorate: Department: Name of
More informationUnofficial copy not valid
Page 2 (9) CONTENTS 1. PURPOSE... 3 2. DEFINITIONS... 3 3. RESPONSIBILITY... 3 4. INVESTIGATOR SELECTION... 3 4.1 Identification of Investigator s... 3 4.2 Initial Contacts... 4 4.3 Distribution of Pre-Study
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationSOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227
SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY SETTING FOR STAFF QUERIES Trust wide All staff involved in research Contact Jess Bisset, Research Operations Manager x20227 Guidance 1. Introduction In accordance
More informationSOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup
SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup Authorship Team: Leanne Quinn for Joint SOP Group on Trial Processes (viz Ian Russell, Anne Seagrove, Jemma Hughes, Yvette
More informationCorporate. Research Governance Policy. Document Control Summary
Corporate Research Governance Policy Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date:
More informationDocument Title: Research Database Application (ReDA) Document Number: 043
Document Title: Research Database Application (ReDA) Document Number: 043 Version: 1.1 Ratified by: Committee Date ratified: 23 February 2017 Name of originator/author: Rachel Fay Directorate: Medical
More informationHuman Research Governance Review Policy
Policy Document Title: Document ID: Document Name: Human Research Governance Review Policy PY-RSH-300304 Human Research Governance Review Policy Version Number: 2 Revision Date: Key Words 28/10/2014 10:40:00
More informationStandard Operating Procedures
Standard Operating Procedures 5.7 Site Initiation Version V1.0 Author/s Approved B Fazekas, S Kochovska D Currow Effective date 30/09/2017 Review date 30/09/2019 DO NOT USE THIS SOP IN PRINTED FORM WITHOUT
More informationVersion Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13
CONTROLLED DOCUMENT Reporting Research Incidents and Breaches Policy CATEGORY: CLASSIFICATION: PURPOSE Controlled Number: Document Policy Governance To set out the framework and principles for reporting
More informationTRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
Reference Number: UHB 317 Version Number: 1 Date of Next Review: 7th July 2019 Previous Trust/LHB Reference Number: N/A TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationRisk Assessment and Monitoring
Version 1.3 Effective date: 25 May 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.3 25 May 2012 Version 1.2 29 January 2010
More informationQuality Assurance Accreditation Scheme Assignment Report 2016/17. University Hospitals of Morecambe Bay NHS Foundation Trust
Quality Assurance Accreditation Scheme Assignment Report 2016/17 Contents 1. Introduction 2. Executive Summary 3. Findings, Recommendations and Action Plan Appendix A: Terms of Reference Appendix B: Assurance
More informationNN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION
NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION SOP: NN SS 401 Version No.: 2.0 Effective Date: 21Oct2016 SITE SELECTION AND QUALIFICATION Supercedes Document:
More informationTrial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs
R&D Department Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored
More informationRisk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research
Risk Assessment Sponsored Research SOP Reference ID: Noclor/Spon/S03/01 Version Number 1.0 Effective Date: 21 st March 2016 It is the responsibility of all users of this SOP to ensure that the correct
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationResearch & Development Quality Manual
Title: Effective Date: 1-4-17 Review Date: 1-4-20 Author: Richard Cowie, QA Manager Version: 3 Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School Document History
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationAbu Dhabi Occupational Safety and Health System Framework (OSHAD-SF) Mechanisms
Abu Dhabi Occupational Safety and Health System Framework (OSHAD-SF) Mechanisms Mechanism 2.0 OSHAD-SF Administration Version 3.1 March 2017 Table of Contents 1. Introduction... 3 2. Roles and Responsibilities...
More informationDocument Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator
including Roles and Responsibilities for the Conduct of Research Studies and Clinical Trials including CTIMPs (Clinical Trials of Investigational Medicinal Products) Document Number: 006 Version: 1 Ratified
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:
More information4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.
SOP #: MON-101 Page: 1 of 6 1. POLICY STATEMENT: The DF/HCC understands that external sponsors are required to monitor the progress of clinical investigations and ensure appropriate research data collection
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationDocument Title: Recruiting Process. Document Number: 011
Document Title: Recruiting Process Document Number: 011 Version: 1.0 Ratified by: Committee Date ratified: 24.06.2014 Name of originator/author: Directorate: Department: Name of responsible individual:
More informationAuditing of Clinical Trials
Version 1.2 Effective date: 3 September 2012 Author: Approved by: Claire Daffern, QA Manager Dr Sarah Duggan, CTU Manager Revision Chronology: Effective Date Version 1.2 3 Sept 2012 Version 1.1 12 May
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Maintaining Training Records SOP Number: 20 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date:
More informationGovernance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise
Queen s University Belfast Research and Enterprise Standard Operating Procedure Research Governance Title: Delegation of Responsibilities SOP Reference QUB-ADRE-005 Date prepared 23 June 2008 Number: Version
More informationGCP INSPECTORATE GCP INSPECTIONS METRICS REPORT
GCP INSPECTORATE GCP INSPECTIONS METRICS REPORT METRICS PERIOD: 1 st April 1 to 31 st March 11 DATE OF ISSUE: 1 th March 1 MHRA Central Region Medicines Inspectorate Falcon Way, Shire Park Welwyn Garden
More informationJoint Statement on the Application of Good Clinical Practice to Training for Researchers
Joint Statement on the Application of Good Clinical Practice to Training for Researchers HRA, MHRA, Devolved Administrations for Northern Ireland, Scotland and Wales v1.1 12/10/17 Summary This joint statement
More informationHuman Samples in Research
Human Samples in Research Adverse Event Reporting Document Identifier HTA-11-SOP-Adverse Event Reporting AUTHOR APPROVER EFFECTIVE DATE: Name and role Signature and date Name and role Signature and date
More informationMonitoring Clinical Trials
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationStudy Monitoring Plan Template
Study Monitoring Plan Template Sponsor Reference Number: Study Title: Principal Investigator: Study Centre: The Sponsor risk assessment form and the trial risk based monitoring strategy appendices 2 &
More informationHarrison Clinical Research. Monitoring of Clinical Trials - Quality Management from a CRO s Perspective
Harrison Clinical Research Monitoring of Clinical Trials - Quality Management from a CRO s Perspective www.harrisonclinical.com 1 17Sep2009 Overview: Monitoring of Clinical Trials 1. Discovering and developing
More informationDetails: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure
Details: Author: Razwan Mahroof - QA Clinical Trials Monitor SOP Pages: 10 Version No. of replaced SOP: 1.0 Effective date of replaced SOP: 04 December 2015 Approval: Version No: of the SOP being approved.
More informationIACUC Policy 09: Researcher Non-Compliance
IACUC Policy 09: Researcher Non-Compliance Policy Intent: The intent of this policy is to define the circumstances, classification, and consequences of research non-compliance with regards to the use of
More informationGCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson
GCP: Investigator Responsibilities Susan Tebbs Nicola Kaganson Investigator Responsibilities Qualifications & agreements Resources Responsibilities to the subject Ethics The protocol The IMP & randomisation
More informationStandard Operating Procedure (SOP) 1 for Chapter 105 Dam Safety Program Review of Chapter 105 New Dam Permit November 2, 2012
Bureau of Waterways Engineering and Wetlands Standard Operating Procedure (SOP) 1 for Chapter 105 Dam Safety Program Review of Chapter 105 New Dam Permit This SOP describes the procedures and work flows
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH Definition of Responsibilities for Externally
More informationTrust Policy and Procedure Document Ref. No: PP (17) 283. Central Alerting System (CAS) Policy and Procedure. For use in: For use by: For use for:
Trust Policy and Procedure Document Ref. No: PP (17) 283 Central Alerting System (CAS) Policy and Procedure For use in: For use by: For use for: Document owner: Status: All areas of the Trust including
More informationStandard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-06-003 Essential Documents: Setting Up a Trial Master File SOP effective: 19 February 2016 Review date: 19 February 2018 SOP author signature:
More informationInformed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019
Standard Operating Procedures (SOP) for: Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019 Author: Reviewer: Reviewer: Authorisation:
More informationABMU R&D Operational Framework
ABMU R&D Operational Framework 2017 ABMU R&D Operational Framework 1 R&D Operational Arrangements University Partnership As a University Health Board, ABMU has signed a Memorandum of Understanding (MOU)
More informationNational Policy Library Document
Page 1 of 11 National Policy Library Document Policy Name: Medicare Programs: Compliance Element VII Prompt Response to Detected Offenses Policy No.: EJ44-83932 Policy Author: Author Title: Author Department:
More informationmanaging or activities.
STANDARD OPERATING PROCEDURE Clinical Research Monitoring TITLE: Site Initiation Visit TITLE: Site Initiation Visit 1. PURPOSE SOP Number: Version: 1.0 MICHR CRM MON 002 Effective Date: 19Dec2013 1.1 This
More informationSite Closedown Checklist for UoL Sponsored CTIMP Studies
Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site
More informationEscalation Procedure. Purpose & definition
Escalation Procedure Purpose & definition This document describes the procedure that the Healthcare Environment Inspectorate will follow to escalate issues or matters of evident concern arising from the
More informationTerms of Reference Executive Research Education & Training Committee
Terms of Reference Executive Research Education & Training Committee 1. Main Authority / Limitations 1.1 The Board hereby resolves to establish a management committee to be known as the Research and Education
More informationOverview of the IMB s. Good Clinical Practice. Deirdre O Regan GCP/Pharmacovigilance. GCP Seminar Dublin, 27 th January 2010.
Overview of the IMB s Approach to Inspection of Good Clinical Practice GCP Seminar Dublin, 27 th January 2010 Deirdre O Regan GCP/Pharmacovigilance Inspection Manager Slide 1 Introductions/Organisation
More informationAppendix 5A. Organization Registration and Certification Manual
Appendix 5A Organization Registration and Certification Manual Effective: October 4, 2013 www.nerc.com Table of Contents Section I Executive Summary... 1 Overview... 1 To Whom Does This Document Apply?...
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationResearch Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012
Research Policy Author: Caroline Mozley Owner: Sue Holden Publisher: Caroline Mozley Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012 Approved by: Executive Board Date approved:
More information